Stacy Wentworth
Papers
1
Total Citations
459
H-Index
1
About
Stacy Wentworth is a leading clinical researcher in radiation oncology, with a primary focus on prostate cancer treatment outcomes and comparative effectiveness. Her most influential work, a landmark 2012 study with 459 citations, provided a comprehensive comparative analysis of prostate-specific antigen (PSA) free survival across low, intermediate, and high-risk prostate cancer patients treated with radical therapy. This study, part of the Prostate Cancer Results Study Group, addressed a critical gap in the literature by systematically evaluating treatment options using PSA as the most sensitive measure of effectiveness. Wentworth’s contributions have helped standardize how clinicians assess treatment success, offering clearer guidance for risk-stratified therapy decisions. Her research is widely cited for its methodological rigor and practical impact on patient counseling. Beyond this seminal work, she has advanced the field by integrating real-world evidence into radiation oncology practice, influencing both clinical guidelines and future trial design. For students and researchers, Wentworth’s work exemplifies how comparative effectiveness research can directly improve cancer care.
Research Focus
Key Achievements
Top Papers
- 1